In multivariable external testing, tumor structure habitat phenotypes from pre-treatment MRI revealed more than a doubling of recurrence risk for women with stage 2 and stage 3 breast cancer.
|Articles|October 23, 1996
ATL signs deal for Chinese Apogee sales
Advanced Technology Laboratories of Bothell, WA, has signed atechnology transfer and distribution agreement with a Chineseultrasound manufacturer for ATL's mid-range Apogee 800 Plus ultrasoundscanner. Under the terms of the deal, ATL will transfer
Advertisement
Advanced Technology Laboratories of Bothell, WA, has signed a
technology transfer and distribution agreement with a Chinese
ultrasound manufacturer for ATL's mid-range Apogee 800 Plus ultrasound
scanner. Under the terms of the deal, ATL will transfer Apogee
800 Plus technology to Shantou Institute of Ultrasonic Instruments
(SIUI). SIUI will manufacture and sell the systems for the China
market, with shipments targeted for the second half of next year.
ATL will continue to manufacture Apogee 800 Plus for all other
international markets. ATL's HDI 3000 high-end scanner is sold
in China by Ultronics Enterprise.
Advertisement
Related to this article
Could a la carte pricing be a consideration in improving revenue for radiologists in private practice?
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Is Private Practice Radiology as Important as an Amusement Park?
3
Can MRI-Derived Tumor Habitat Subregions Bolster Recurrence Risk Stratification in Stage 2 and 3 Breast Cancer Cases?
4
Radiology Roundup of FDA News: September 13 — September 19
5